Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(15 sites)

United States

Childrens Hospital Colorado, Aurora, Colorado

Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania

Prim Childrens Hosp Inv Pharm, Salt Lake City, Utah

Australia

Novartis Investigative Site, Brisbane, Queensland

Novartis Investigative Site, Nedlands, Western Australia